Interference of the IGF system as a strategy to inhibit breast cancer growth
- 1 February 1992
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 22 (1) , 101-106
- https://doi.org/10.1007/bf01833338
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.Journal of Clinical Investigation, 1992
- The insulin-like growth factor binding proteins (IGFBPs) in human breast cancerBreast Cancer Research and Treatment, 1992
- Recombinant Toxins for Cancer TreatmentScience, 1991
- Progestins Induce Down-Regulation of Insulin-Like Growth Factor-I (IGF-I) Receptors in Human Breast Cancer Cells: Potential Autocrine Role of IGF-IIMolecular Endocrinology, 1991
- Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.Journal of Clinical Investigation, 1989
- Characterization of Insulin-Like Growth Factor Binding Proteins from Human Breast Cancer CellsMolecular Endocrinology, 1989
- Analysis of Insulin-Like Growth Factor I Gene Expression in Malignancy: Evidence for a Paracrine Role in Human Breast CancerMolecular Endocrinology, 1989
- The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cellsBiochemical and Biophysical Research Communications, 1989
- Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.Proceedings of the National Academy of Sciences, 1987
- Estrogen-Induced Factors of Breast Cancer Cells Partially Replace Estrogen to Promote Tumor GrowthScience, 1986